Voyager Technologies, Inc. (VOYG) SEC Filings & Earnings Calls
EquiReason read 16 Voyager Technologies, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-28 — Voyager Technologies issues 0% Convertible Senior Notes due 2032, enters capped call transactions, and amends credit agreement. Significant capital structure event..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
4 Aug 202610-QVoyager reported Q2 2026 revenue of $52.7M (+15.5% YoY), with strong backlog of $335.5M and continued NASA grant funding for Starlab.earningsopen
Figures in the filing · each found in the filing text
| Total Backlog · Q2-2026 | $336M | |
| Funded Backlog · Q2-2026 | $189M | |
| Revenue · Q2-2026 | $53M | +16% y/y |
Risks flagged
Customer concentration
“As of June 30, 2026, 87.7% of the total dollar value of our funded backlog related to our top customer, the U.S. government.” · word for word
Contract cancellation risk
“In general, our customers have the right to cancel their contracts under termination for convenience clauses.” · word for word
Fixed-price contract margin risk
“If our fixed-price development efforts create a larger portion of our revenue output, we may have a higher risk profile, which may result in reduced margins.” · word for word
Budget uncertainty
“A reduction in the amount of, or reductions, delays, or cancellations of funding for, services that we are contracted to provide to the U.S. government due to any of these impacts or related initiatives, legislation or otherwise could have a material adverse effect on our business and results of operations.” · word for word
3 Aug 20268-K · 2.02Quarterly revenue $53M; Quarterly bookings $113M; Backlog $336M; Guidance: FY2026 revenue guidance raised to $275M-$305M (66%-84% YoY growth)earningsopen
Figures in the filing · each found in the filing text
| Quarterly revenue · Q2-2026 | $53M | |
| Quarterly bookings · Q2-2026 | $113M | |
| Backlog · Q2-2026 | $336M | |
| Net loss · Q2-2026 | $-47M | |
| Non-GAAP adjusted loss · Q2-2026 | $-41M | |
| Non-GAAP Adjusted EBITDA · Q2-2026 | $-38M | |
| Cash and cash equivalents · Q2-2026 | $373M |
Guidance
FY2026 revenue guidance raised to $275M-$305M (66%-84% YoY growth)
Raised FY revenue guidance significantly; record backlog provides visibility; still loss-making.
Risks flagged
Significant net loss and negative EBITDA; high innovation spend (102% of revenue) may not translate to profitability soon.
“Net loss $(46.5)M; Adjusted EBITDA $(37.5)M; innovation spend 102% of revenue.”
5 May 202610-QTotal Backlog $275M; Funded Backlog $153M; Net Sales $35M (+2% y/y)open
Figures in the filing · each found in the filing text
| Total Backlog · 2026-03-31 | $275M | |
| Funded Backlog · 2026-03-31 | $153M | |
| Net Sales · Q1-2026 | $35M | +2% y/y |
| Net Sales - U.S. Government · Defense and Space Technologies · Q1-2026 | $30M | +1% y/y |
| Net Sales - Commercial and International · Defense and Space Technologies · Q1-2026 | $6M | +12% y/y |
| Gross Research and Development Costs · Q1-2026 | $13M | +118% y/y |
| Government Grant Assistance Offset Against R&D · Q1-2026 | $6M | +180% y/y |
| Government Grant Assistance Offset Against Construction in Progress · Q1-2026 | $20M | +14% y/y |
| Cumulative Starlab Milestone Payments Earned · Starlab Space Stations · 2026-03-31 | $207M |
Risks flagged
Customer Concentration Risk
“As of March 31, 2026, 83.5% of the total dollar value of our funded backlog related to our top customer, the U.S. government.” · word for word
Fixed-Price Contract Margin Risk
“If our fixed-price development efforts create a larger portion of our revenue output, we may have a higher risk profile, which may result in reduced margins.” · word for word
Government Budget Uncertainty
“Any disruption in the functioning of government agencies, including as a result of government closures and shutdowns, could have a negative impact on our operations and cause us to lose revenue or incur additional costs.” · word for word
4 May 20268-K · 2.02Backlog $275M (+54% y/y); Bookings $45M; Book-to-Bill ratio 1.3; Guidance: 2026 revenue guidance raised to $230-255M (39-53% growth over 2025)earningsopen
Figures in the filing · each found in the filing text
| Backlog · 2026-03-31 | $275M | +54% y/y |
| Bookings · Q1-2026 | $45M | |
| Book-to-Bill ratio · Q1-2026 | $1.30 | |
| Net sales · Q1-2026 | $35M | |
| Cash and cash equivalents · 2026-03-31 | $429M | |
| Total liquidity · 2026-03-31 | $641M | |
| Net loss · Q1-2026 | $-44M | |
| Non-GAAP adjusted loss · Q1-2026 | $-36M | |
| Non-GAAP Adjusted EBITDA · Q1-2026 | $-33M | |
| Innovation spend as % of net sales (consolidated) · Q1-2026 | 151.0% |
Guidance
2026 revenue guidance raised to $230-255M (39-53% growth over 2025)
Record backlog and strong bookings drive significant guidance raise; current losses due to investment.
Risks flagged
Current net loss and negative EBITDA due to heavy investment in Starlab and innovation.
“Net loss $(44.0)M; Adjusted EBITDA $(33.3)M; innovation spend 151% of net sales.”
Dependence on government contracts and defense spending priorities.
“Revenue tied to Golden Dome, NASA, and other government programs; contract wind-down noted.”
17 Apr 2026DEF 14AThe company is proposing to redomesticate from Delaware to Texas, changing its legal domicile and governance framework.open
Risks flagged
Governance and Legal Uncertainty from Redomestication
“The newly created Texas Business Court is already hearing cases but will need time to develop reputationally and build a body of case law that provides comparable levels of guidance to directors and officers but may also reference Delaware and other states’ precedent on cases or instances of first impression.” · word for word
Potential Stockholder Criticism and Negative Perception
“Certain provisions of the TBOC...may garner opposition or criticism from institutional shareholders, proxy advisory firms (such as ISS and Glass Lewis) or other governance commentators, which could negatively affect our business and reputation.”
Transaction Costs and Potential Litigation
“The Company will also incur certain non-recurring costs in connection with the Texas Redomestication...It is also possible that the Texas Redomestication results in additional litigation, regardless of merit, with additional expense, distraction, and time of the Company and management to address such litigation.” · word for word
10 Mar 202610-KRevenue $166M (+15% y/y); Employees 800 (+60% y/y)open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $166M | +15% y/y |
| Employees · 2025-12-31 | 800 | +60% y/y |
Risks flagged
Fixed-price contract risk
“Several of our existing contracts with the U.S. government are fixed-price contracts. Under firm, fixed-price contracts, work performed and products shipped are priced at a fixed amount without adjustment for actual costs incurred in connection with the contract. These contracts carry the risk of potential cost overruns because we assume all of the cost burd” · word for word
Growth management risk
“We may not be able to generate, sustain and manage our growth due to a variety of external factors.” · word for word
Dilution risk
“You may be diluted by the future issuance of additional common stock in connection with our incentive plans, acquisitions or otherwise.” · word for word
Technology integration risk
“Our products and services embody complex technology and may not always be compatible with current and evolving technical standards and systems developed by others.” · word for word
9 Mar 20268-K · 2.02Net sales $166M (+15% y/y); Net sales $47M (+24% y/y); Total Backlog $266M (+33% y/y); Guidance: 2026 revenue guidance raised to $225-255M from prior range (not disclosed); implies 35-53% YoY growthearningsopen
Figures in the filing · each found in the filing text
| Net sales · FY2025 | $166M | +15% y/y |
| Net sales · Q4-2025 | $47M | +24% y/y |
| Total Backlog · 2025-12-31 | $266M | +33% y/y |
| Funded backlog · 2025-12-31 | $146M | |
| Net loss · Q4-2025 | $-30M | |
| Net loss · FY2025 | $-116M | |
| Non-GAAP Adjusted EBITDA · Q4-2025 | $-22M | |
| Non-GAAP Adjusted EBITDA · FY2025 | $-70M | |
| Total liquidity · 2025-12-31 | $705M | |
| Defense and National Security segment net sales · Defense and National Security · Q4-2025 | $36M | +63% y/y |
Guidance
2026 revenue guidance raised to $225-255M from prior range (not disclosed); implies 35-53% YoY growth
Voyager raised 2026 revenue guidance based on record backlog and accelerating defense/space demand; still in heavy investment phase with negative earnings.
Risks flagged
Heavy net losses and negative EBITDA indicate significant investment phase with uncertain path to profitability.
“full year net loss of $(116.1) million; Non-GAAP Adjusted EBITDA of $(69.9) million” · word for word
Space Solutions segment declining due to NASA contract wind-down; revenue concentration risk in defense.
“Space Solutions segment net sales declined $5.2 million, or 29% year over year, to $12.5 million primarily due to the anticipated conclusion of a multi-year service contract with NASA.” · word for word
Guidance acknowledges uncertainty from potential government shutdown.
“while recognizing uncertainty in the near-term attributable to the government shutdown.” · word for word
25 Nov 20258-K · 1.01, 2.03, 3.02, 8.01Entered a material definitive agreement (acquisition, partnership, or major contract); took on a material direct financial obligation, increasing leverageopen
Risks flagged
Insufficient information to assess risk; filing is incomplete in excerpt.
13 Nov 20258-K · 1.01, 2.03, 3.02, 8.01Convertible Note Interest Rate 0.75open
Figures in the filing · each found in the filing text
| Convertible Note Interest Rate · total · Q4-2025 | 0.8% |
Risks flagged
Increased leverage from convertible notes
“Issuance of 0.75% Convertible Senior Notes due 2030”
4 Nov 202510-QVoyager Technologies reported Q3 2025 results with flat revenue YoY, but significant growth in Defense and National Security segment offset by decline in Space Solutions; net loss widened due to higher operating expenses and cost overruns.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $40M | 0% y/y |
| Net sales · 9M-2025 | $120M | +13% y/y |
| Net loss attributable to Voyager Technologies, Inc. · Q3-2025 | $-16M | |
| Net loss attributable to Voyager Technologies, Inc. · 9M-2025 | $-75M | |
| Cash and cash equivalents · 2025-09-30 | $413M | |
| Funded backlog · 2025-09-30 | $88M | |
| Total backlog · 2025-09-30 | $189M | |
| Capital expenditures · 9M-2025 | $96M | +82% y/y |
| Adjusted EBITDA · Q3-2025 | $-18M | |
| Adjusted EBITDA · 9M-2025 | $-48M |
Risks flagged
Customer Concentration
“As of September 30, 2025, approximately 62.6% of the total dollar value of our funded backlog related to three customers.” · word for word
Program Cost Overruns
“Net EAC adjustments: Three Months Ended September 30, 2025: $(4,272); Nine Months Ended September 30, 2025: $(10,457).”
Dependence on Government Funding
“Our results can be affected by shifts in strategies and priorities on defense-related programs, commercial space exploration, and space infrastructure.” · word for word
History of Losses
“Net loss attributable to Voyager Technologies, Inc. $(74,593) for the nine months ended September 30, 2025.” · word for word
Starlab Program Execution Risk
“Starlab Space Stations segment Adjusted EBITDA was $(6,150) for the three months ended September 30, 2025, driven by increased operating expenses and R&D costs.”
3 Nov 20258-K · 2.02Net sales $40M (+0% y/y); Defense and National Security segment net sales $28M (+31% y/y); Space Solutions segment net sales $12M (-41% y/y); Guidance: FY2025 revenue expected towards high-end of $165M-$170M rangeearningsopen
Figures in the filing · each found in the filing text
| Net sales · consolidated · Q3-2025 | $40M | 0% y/y |
| Defense and National Security segment net sales · Defense and National Security · Q3-2025 | $29M | +31% y/y |
| Space Solutions segment net sales · Space Solutions · Q3-2025 | $12M | -41% y/y |
| Net loss · consolidated · Q3-2025 | $-16M | |
| Loss per share · consolidated · Q3-2025 | $-0.28 | |
| Non-GAAP adjusted loss · consolidated · Q3-2025 | $-13M | |
| Non-GAAP adjusted loss per share · consolidated · Q3-2025 | $-0.22 | |
| Non-GAAP Adjusted EBITDA · consolidated · Q3-2025 | $-18M | |
| Total backlog · consolidated · Q3-2025 | $189M | |
| Funded backlog · consolidated · Q3-2025 | $88M |
Guidance
FY2025 revenue expected towards high-end of $165M-$170M range
Revenue guidance raised to high-end; defense demand strong; EBITDA loss reflects Starlab investment.
Risks flagged
Space Solutions segment revenue decline due to NASA contract wind-down; net loss and negative EBITDA persist.
“Space Solutions segment net sales declined 41% YoY; net loss of $(16.3)M; adjusted EBITDA $(17.7)M.”
Government shutdown uncertainty could impact near-term performance.
“recognizing uncertainty in the near-term attributable to the government shutdown.” · word for word
Voyager Technologies, Inc. — questions
- What did Voyager Technologies, Inc. file recently?
- 16 SEC filings in the last 12 months. Latest: 8-K on 2026-09-28 — Voyager Technologies issues 0% Convertible Senior Notes due 2032, enters capped call transactions, and amends credit agreement. Significant capital structure event.
Every figure on this page comes from Voyager Technologies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.